Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,853,367
+$3,898,627 QoQ
Shares Held
328,819
+45.7% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 192 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. SLS ranks #66 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in SLS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,853,367 328,819
2026-03-31 $954,740 225,707
2025-12-31 $1,128,379 299,305
2025-09-30 $122,145 75,867
2025-06-30 $117,854 53,815
2025-03-31 $3,243 3,003
2024-03-31 $304 301
2023-12-31 $17,337 16,357
2023-09-30 $26,759 16,317
2023-06-30 $25,612 16,314
2023-03-31 $23,083 16,142
2022-12-31 $38,090 16,140
2022-09-30 $22,494 11,136
2022-06-30 $24,835 11,137
2022-03-31 $40,734 6,098
2021-12-31 $36,552 6,610
2021-09-30 $37,647 4,110
2021-06-30 $76,079 6,854
2021-03-31 $58,370 6,835
2020-12-31 $319 55
2020-09-30 $145 55
2020-06-30 $131 45
2020-03-31 $65 38